Weekly Roundup: One month till Optimum’s Annual Healthcare Investor Conference
ViaNautis Bio welcomed SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury ViaNautis Bio, the biotech developing polyNaut® for precise, non‑viral delivery of genetic medicines, announced that SCI Ventures, a specialist venture fund backed by leading clinical centres and research foundations worldwide focused on advancing treatments and cures for paralysis, has joined the […]




